The Impact of Corticosteroid Therapy on Patients With West Nile Virus: A Retrospective Cohort Study
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf601 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Itamar Poran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel. Hauptthemen laut MEDLINE: West Nile Fever, Adrenal Cortex Hormones. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
West Nile virus (WNV) infection may result in a serious, neuroinvasive, life-threatening disease. Since there is no known therapy against the virus, treatment is based on supportive care. Little is known about the effect of corticosteroids (CS) in patients with West Nile, and their use remains controversial. This study aimed to evaluate the effect of CS treatment in patients with WNV infection.
Methods
A retrospective cohort study was conducted at Rabin Medical Center, including patients with WNV infection. Data were extracted from patients’ electronic medical records. Inverse probability of treatment weighting was used to adjust patient characteristics. Our exposure of interest was CS prescription during the first 48 hours. IPTW-adjusted Cox proportional hazard models were used to compare the risk of hospital mortality. Secondary outcomes included the need for mechanical ventilation or intensive care unit transfer, and the need for rehabilitation or a long-term care facility at discharge.
Results
Data from 150 confirmed cases were extracted. 41 (27%) patients received CSs. After adjusting for potential confounders, CS treatment was found to significantly increase hospital mortality (adjusted hazard ratio [aHR] 3.93, 95% confidence interval [CI] 1.14–13.51). A sensitivity analysis including patients with West Nile neuroinvasive disease and patients hospitalized for more than 48 hours showed consistent results.
Conclusions
Our study suggests that CS use in WNV patients may be associated with an increased risk of hospital mortality, highlighting the need for caution in their use and further prospective investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine E, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.
- School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
- Infectious Disease Unit, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.
ORCID-Profile: Itamar Poran
Zitieren
APA
Poran, I., Basharim, B., Leibovici-Weissman, Y., Michaelis, M., Ghantous, N., & Eliakim-Raz, N. (2025). The Impact of Corticosteroid Therapy on Patients With West Nile Virus: A Retrospective Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf601
Vancouver
Poran I, Basharim B, Leibovici-Weissman Y, Michaelis M, Ghantous N, Eliakim-Raz N. The Impact of Corticosteroid Therapy on Patients With West Nile Virus: A Retrospective Cohort Study. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf601
BibTeX
@article{Poran2025,
author = {Poran, Itamar and Basharim, Bar and Leibovici-Weissman, Yaara and Michaelis, Michal and Ghantous, Nassem and Eliakim-Raz, Noa},
title = {The Impact of Corticosteroid Therapy on Patients With West Nile Virus: A Retrospective Cohort Study},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf601}
}
EUVIMED